These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 11925618
1. Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats. Wang X, Zhong YX, Zhang ZY, Lu J, Lan M, Miao JY, Guo XG, Shi YQ, Zhao YQ, Ding J, Wu KC, Pan BR, Fan DM. World J Gastroenterol; 2002 Apr; 8(2):328-32. PubMed ID: 11925618 [Abstract] [Full Text] [Related]
5. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites]. Ortiz MC, Fortepiani LA, Martínez-Salgado C, Eleno N, Atucha NM, López-Novoa JM, García-Estañ J. Nefrologia; 2001 Apr; 21(6):556-64. PubMed ID: 11881425 [Abstract] [Full Text] [Related]
6. [Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats]. Huang Y, Xiao S, Zhang D. Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):139-42. PubMed ID: 10923428 [Abstract] [Full Text] [Related]
7. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Weigert AL, Martin PY, Niederberger M, Higa EM, McMurtry IF, Gines P, Schrier RW. Hepatology; 1995 Dec; 22(6):1856-62. PubMed ID: 7489998 [Abstract] [Full Text] [Related]
8. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Pfeiffer S, Leopold E, Schmidt K, Brunner F, Mayer B. Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069 [Abstract] [Full Text] [Related]
9. Reduced susceptibility to epinephrine-induced arrhythmias in cirrhotic rats: the roles of nitric oxide and endogenous opioid peptides. Tavakoli S, Hajrasouliha AR, Jabehdar-Maralani P, Ebrahimi F, Solhpour A, Sadeghipour H, Ghasemi M, Dehpour AR. J Hepatol; 2007 Mar; 46(3):432-9. PubMed ID: 17125877 [Abstract] [Full Text] [Related]
10. Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide? Mathie RT, Ralevic V, Moore KP, Burnstock G. Hepatology; 1996 Jan; 23(1):130-6. PubMed ID: 8550032 [Abstract] [Full Text] [Related]
11. Altered mesenteric venous capacitance and volume pooling in cirrhotic rats are mediated by nitric oxide. Li Y, Liu H, Gaskari SA, Tyberg JV, Lee SS. Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G252-9. PubMed ID: 18556420 [Abstract] [Full Text] [Related]
13. Potential excitatory role of nitric oxide on 2-deoxy-d-glucose-induced gastric motility in rats. Sevgili AM, Balkanci DZ, Erdem A. Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):693-699. PubMed ID: 28294385 [Abstract] [Full Text] [Related]
14. Potentiation of motilin-induced contraction by nitric oxide synthase inhibition in the isolated chicken gastrointestinal tract. Kitazawa T, Onodera C, Taneike T. Neurogastroenterol Motil; 2002 Feb; 14(1):3-13. PubMed ID: 11874549 [Abstract] [Full Text] [Related]
15. Role of reduced glutathione and nitric oxide in the black tea extract-mediated protection against ulcerogen-induced changes in motility and gastric emptying in rats. Maity S, Vedasiromoni JR, Chaudhuri L, Ganguly DK. Jpn J Pharmacol; 2001 Apr; 85(4):358-64. PubMed ID: 11388638 [Abstract] [Full Text] [Related]